loading
Schlusskurs vom Vortag:
$1.39
Offen:
$1.39
24-Stunden-Volumen:
641.63K
Relative Volume:
0.66
Marktkapitalisierung:
$102.89M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-292.19M
KGV:
-0.315
EPS:
-4.54
Netto-Cashflow:
$-208.41M
1W Leistung:
+6.72%
1M Leistung:
+10.00%
6M Leistung:
-36.73%
1J Leistung:
-64.34%
1-Tages-Spanne:
Value
$1.3802
$1.46
1-Wochen-Bereich:
Value
$1.34
$1.485
52-Wochen-Spanne:
Value
$1.01
$5.44

Zentalis Pharmaceuticals Inc Stock (ZNTL) Company Profile

Name
Firmenname
Zentalis Pharmaceuticals Inc
Name
Telefon
(858) 263-4333
Name
Adresse
10275 SCIENCE CENTER DRIVE, SAN DIEGO, NY
Name
Mitarbeiter
166
Name
Twitter
@ZentalisP
Name
Nächster Verdiensttermin
2025-03-26
Name
Neueste SEC-Einreichungen
Name
ZNTL's Discussions on Twitter

Vergleichen Sie ZNTL mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ZNTL
Zentalis Pharmaceuticals Inc
1.43 96.42M 0 -292.19M -208.41M -4.54
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Zentalis Pharmaceuticals Inc Stock (ZNTL) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-08-12 Hochstufung Wedbush Underperform → Neutral
2024-06-20 Herabstufung UBS Buy → Neutral
2024-06-18 Herabstufung Jefferies Buy → Hold
2024-06-18 Herabstufung Morgan Stanley Overweight → Equal-Weight
2024-06-18 Herabstufung Wedbush Neutral → Underperform
2024-06-18 Herabstufung Wells Fargo Overweight → Equal Weight
2023-11-08 Herabstufung Wedbush Outperform → Neutral
2023-11-07 Herabstufung Leerink Partners Outperform → Market Perform
2022-07-12 Eingeleitet Cowen Outperform
2022-04-06 Eingeleitet Wells Fargo Overweight
2021-10-07 Fortgesetzt Jefferies Buy
2021-09-30 Eingeleitet Stifel Buy
2021-09-29 Eingeleitet Oppenheimer Outperform
2021-05-21 Eingeleitet UBS Buy
2021-01-20 Eingeleitet Wedbush Outperform
2020-09-29 Eingeleitet Cantor Fitzgerald Overweight
2020-08-27 Eingeleitet H.C. Wainwright Buy
2020-04-28 Eingeleitet Guggenheim Buy
2020-04-28 Eingeleitet Jefferies Buy
2020-04-28 Eingeleitet Morgan Stanley Overweight
2020-04-28 Eingeleitet SVB Leerink Outperform
Alle ansehen

Zentalis Pharmaceuticals Inc Aktie (ZNTL) Neueste Nachrichten

pulisher
Jul 22, 2025

Zentalis Pharmaceuticals Inc. Stock Analysis and ForecastOutstanding capital returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Zentalis Pharmaceuticals Inc. stock priceHigh-impact stock picks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 20, 2025

What analysts say about Zentalis Pharmaceuticals Inc. stockFree Trading Strategy Suggestions - printweek.in

Jul 20, 2025
pulisher
Jul 20, 2025

Is Zentalis Pharmaceuticals Inc. a good long term investmentExplosive returns - jammulinksnews.com

Jul 20, 2025
pulisher
Jul 15, 2025

Why Zentalis Pharmaceuticals Inc. stock attracts strong analyst attentionPrecision Entry Strategy - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Zentalis Pharmaceuticals Inc. stock price move sharplyHigh Return Investment Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Zentalis Pharmaceuticals Inc. stock performs during market volatilityDaily Swing Candidates - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

Insider Stock Buyers At Zentalis Pharmaceuticals Recouped Some Losses This Week - simplywall.st

Jul 14, 2025
pulisher
Jul 12, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Average Rating of “Moderate Buy” by Brokerages - Defense World

Jul 12, 2025
pulisher
Jul 07, 2025

Wealth Enhancement Advisory Services LLC Purchases 33,958 Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jul 07, 2025
pulisher
Jul 01, 2025

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - TradingView

Jul 01, 2025
pulisher
Jul 01, 2025

Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | ZNTL Stock News - GuruFocus

Jul 01, 2025
pulisher
Jun 30, 2025

Zentalis Pharmaceuticals, Inc.(NasdaqGM:ZNTL) dropped from Russell Small Cap Completeness Index - MarketScreener

Jun 30, 2025
pulisher
Jun 18, 2025

Zentalis Pharmaceuticals shareholders elect three directors at annual meeting - Investing.com

Jun 18, 2025
pulisher
Jun 17, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives Average Rating of “Hold” from Brokerages - Defense World

Jun 17, 2025
pulisher
Jun 12, 2025

Wealth Enhancement Advisory Services LLC Raises Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jun 12, 2025
pulisher
Jun 10, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Shares Sold by Bank of America Corp DE - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Squarepoint Ops LLC Reduces Stake in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jun 09, 2025
pulisher
Jun 06, 2025

Ameriprise Financial Inc. Purchases New Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Zentalis Pharmaceuticals Announces Azenosertib Fast Track Designation and Virtual Corporate Event to Present Updated Data from Azenosertib Clinical Studies - The Globe and Mail

Jun 05, 2025
pulisher
Jun 05, 2025

ProShare Advisors LLC Lowers Holdings in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Why Did Zentalis Pharmaceuticals Inc. (ZNTL) Plunge 11.33%? - AInvest

Jun 05, 2025
pulisher
Jun 04, 2025

Nuveen Asset Management LLC Has $1.94 Million Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jun 04, 2025
pulisher
Jun 04, 2025

Deutsche Bank AG Grows Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jun 04, 2025
pulisher
Jun 03, 2025

Two Sigma Investments LP Sells 291,801 Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

Jun 03, 2025
pulisher
Jun 02, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | ZNTL Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Jun 02, 2025
pulisher
Jun 02, 2025

Zentalis Expands Cancer Research Team: 137K Share Options Granted to Key New Hires - Stock Titan

Jun 02, 2025
pulisher
Jun 02, 2025

Zentalis Pharmaceuticals Presents Promising Study Results at ASCO - TipRanks

Jun 02, 2025
pulisher
Jun 01, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Shares Acquired by Millennium Management LLC - Defense World

Jun 01, 2025
pulisher
May 28, 2025

Northern Trust Corp Raises Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

May 28, 2025
pulisher
May 25, 2025

BNP Paribas Financial Markets Invests $534,000 in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

May 25, 2025
pulisher
May 23, 2025

Captrust Financial Advisors Buys New Stake in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

May 23, 2025
pulisher
May 23, 2025

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Average Rating of “Hold” by Analysts - Defense World

May 23, 2025
pulisher
May 23, 2025

Jane Street Group LLC Boosts Stock Holdings in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

May 23, 2025
pulisher
May 20, 2025

Zentalis Pharmaceuticals at H.C. Wainwright BioConnect Conference - TipRanks

May 20, 2025
pulisher
May 19, 2025

Balyasny Asset Management L.P. Has $175,000 Stock Position in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) - Defense World

May 19, 2025
pulisher
May 19, 2025

Wedbush Issues Optimistic Outlook for ZNTL Earnings - Defense World

May 19, 2025
pulisher
May 17, 2025

Wedbush Reaffirms Neutral Rating for Zentalis Pharmaceuticals (NASDAQ:ZNTL) - Defense World

May 17, 2025
pulisher
May 16, 2025

Zentalis Pharmaceuticals First Quarter 2025 Earnings: US$0.67 loss per share (vs US$0.14 profit in 1Q 2024) - Yahoo Finance

May 16, 2025
pulisher
May 16, 2025

Zentalis Pharmaceuticals Reports Q1 2025 Financial Results - TipRanks

May 16, 2025
pulisher
May 15, 2025

ZNTL Advances Azenosertib Development Amid Strategic Progress | - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Analyst Reiterates Neutral Rating for Zentalis Pharma (ZNTL) | Z - GuruFocus

May 15, 2025
pulisher
May 15, 2025

ZNTL: Oppenheimer Adjusts Price Target Amid Regulatory Developme - GuruFocus

May 15, 2025
pulisher
May 15, 2025

ZNTL: Oppenheimer Adjusts Price Target Amid Regulatory Developments | ZNTL Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Zentalis Pharma (ZNTL) Receives Buy Rating from HC Wainwright & Co. | ZNTL Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

22,440 Shares in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Bought by Raymond James Financial Inc. - Defense World

May 15, 2025

Finanzdaten der Zentalis Pharmaceuticals Inc-Aktie (ZNTL)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Zentalis Pharmaceuticals Inc-Aktie (ZNTL) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Bruns Ingmar
Chief Medical Officer
Feb 06 '25
Buy
2.28
20,000
45,656
36,629
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):